BACKED VC

This Wednesday, we marked the one-year anniversary of LONDON BIO – a forum that has quickly become a hub for the sharpest minds in biotech to share war stories, debate the challenges of biotech development and explore cutting-edge innovations. We welcomed keynote speakers Emma Tinsley (CEO, Weatherden) and Dr. Edwin Moses (Chairman, LabGenius) who spoke with aplomb. Interviewed by Jack O’Meara co-founder of Ochre Bio and Dr. James Field, CEO LabGenius respectively, our speakers shared witty anecdotes alongside insights into deeply tricky decisions. We left the night inspired, knowing that we’re not just talking about the future of biotech – we’re actively building it. See the blog coming out next week to dissect more about the evening. 🔬 Every quarter we gather 80 techbio and life sciences practitioners from across London, Oxford, and Cambridge to share ideas, connect, and push the boundaries of innovation. Co-founded by Alex Brunicki, Yasmin Siraj from BACKED and Jack O'Meara, founder of Ochre Bio to serve the capital’s biotech need for a close community. A huge thanks to our sponsors, Amazon Web Services (AWS) (Patricia Suhrcke, Natalie Holman-Shepherd), HSBC Innovation Banking (Davide Bommarito, Ph.D., Emily Pilkington), and Dawn Capital (Samuel Jervier) for helping make this event possible. And of course, a special shoutout to all the attendees for contributing to such an insightful and exciting evening. We're already looking forward to the next edition of LONDON BIO where we’ll continue to push the conversation forward in this ever-evolving field. #LONDONBIO #Biotech #TechBio #Innovation #BACKEDVC

Huge welcome to the clan Lucia Cerchlan 🏴 Lucia brings a wealth of experience as an operator, entrepreneur and angel investor to support our Founders post-investment.💥 Show her some love and be sure to connect to stay in the know with what's coming up in our Founder Experience programme and upcoming events! #FounderExperience #BACKEDVC #Welcome

LONDON BIO doors open in an hour. We look forward to seeing you all!

Next week on 10th September, Andre de Haes is hitting the main stage at TechBBQ’s Nordic Investor Day in Copenhagen. Andre will join Joe Perkins (Landscape), Meagan Loyst (GenZ.vc), and jager mcconnell (Crunchbase) to dive into one of the big questions on everyone's mind: "Will AI cause job loss in venture?" Expect fresh takes and solid insights from the panel. If you’re at Nordic Investor Day, don’t miss it! With thanks to the TechBBQ team Michael Bak and Kay Michelsen for organising a stellar line up and full programme that week. #TechBBQ #AI #VentureCapital #NordicInvestorDay #FrontierTech #Copenhagen

September is here which means it’s time to shake the dust off your CV and dive into our Talent Portal.🌟 Companies are ramping up hiring efforts before the year ends, and our portfolio has 180+ exciting opportunities open. Marketeers, this one’s for you - could one of these global roles be your next big move? 1️⃣ Head of Data - Immutable (Sydney, Australia) Lead data strategies at a pioneering web3 gaming company. https://lnkd.in/eZQtM98p 2️⃣ Marketing Manager - AI Training - Invisible (Remote) Shape the future of AI with strategic content at a hyper-growth company. https://lnkd.in/eDfmkfuJ 3️⃣ Senior Marketing Operations Specialist - Amenitiz (Barcelona, Spain) Optimise and drive marketing efficiency at a fast-growing travel tech titan. https://lnkd.in/eEGkDcWH 📝 Ready to level up your career? Apply today! Check out all the open roles on the BACKED Portal: https://lnkd.in/eA3wm_bY #MarketingCareers #hiring #HiringNow #TechCareers #Web3 #Blockchain #AI

Are you a #lifesciences or #techbio practitioner? We would like to invite you to join us for the next #LONDONBIO! We are bringing together some of the leading minds in European biotech for an evening of networking and discussions about how to scale in bio. You’ll have the chance to hear directly from two seasoned biotech experts: 💫 Dr. Edwin Moses, a serial entrepreneur who has led successful IPOs and is Chair of the LabGenius Board, among other roles.  Chairman of the Board at Achilles Therapeutics, Avantium NV and LabGenius Serial entrepreneur and value creator in European life science companies. As CEO built two businesses (Oxford Asymmetry International plc and Ablynx nv), led their successful IPOs on the LSE, EuroNext and NASDAQ and raised over €500M in equity and debt financing. Was responsible for developing the business plans and implementing them. Ran the sales process for each company generating values of £316M and €3.9Bn respectively. Expertise in high value service provision to the pharmaceutical industry and in drug discovery and development. Primarily focussed on high growth businesses and change management. 25 years of Board level experience in more than 10 companies, mostly as Chairman. 💫 Emma Tinsely is CEO of Weatherden, a global clinical development consultancy. Emma is CEO of Weatherden, a global clinical development consultancy. Over the past 7 years, Weatherden has substantially improved PTRS in early clinical development (CS to PoC, with a success rate of 65% vs. industry average of 29%. Weatherden has partnered with over 200 biotech companies and funds, and the programmes it has been involved with have generated >$25 billion in value through M&A and partnering deals. Before co-founding Weatherden, Emma was at SV Health Investors working on VC company creation, forming 5 biotech companies across immunology and oncology. Prior to that she was in the Life Sciences team at KPMG.  📆 Wednesday 4th September 2024, 17:30-21:00 👉 RSVP to secure your place: https://lnkd.in/ek78F8vh With thanks to our partners Amazon Web Services (AWS), HSBC Innovation Banking and Dawn Capital. Alex Brunicki Yasmin Siraj Jack O'Meara Samuel Jervier Jack Tunmore James Field Patricia Suhrcke Kosten Metreweli Alex Merwin Emily Pilkington Davide Bommarito, Ph.D. Victoria Gregory Alex Hazell Ochre Bio #biotech #drugdiscovery #entrepreneurship

🔥 "We Need More Apps!" 🔥 In his latest blog, our blockchain investor, Henry Ang, dives deep into the current landscape of the crypto world, highlighting the need for a shift in focus from infrastructure to application development. As capital allocators, we "have huge responsibility in shaping the industry" by backing the next wave of breakthrough applications in blockchain. 🎯 "At BACKED, our approach is to look at infrastructure deals opportunistically and spend most of our time assessing projects on the application layer." 🚀  Henry explores why the application layer is undervalued, the opportunities that lie within, and how we at BACKED are positioning ourselves for the future. 🔗 Read the full blog and discover how we're driving change in the blockchain industry: https://lnkd.in/eMM-WqEP If you're a developer building in this space, this one's for you. #Blockchain #DeFi #Crypto #VentureCapital #Innovation #AppLayer #BACKEDVC Alex Brunicki Andre de Haes

We love seeing our Founders in high places! 🍎🗽 👏 Emma Sinclair MBE EnterpriseAlumni

2024 is booming for BACKED's biotech family! From Ochre Bio 's double pharma contracts, to LabGenius's Series B raise and now ground-breaking news from Nuntius Therapeutics who just announced a strategic collaboration! 🚀🚀🚀 Today, Nuntius confirmed with collaboration with Taiho Pharmaceutical to develop next-gen mRNA cancer immunotherapies using their advanced nanocarrier technology. Nuntius’ innovative approach tackles some of the biggest challenges in mRNA delivery, offering targeted, cell-specific delivery without the immunogenic and off-target effects seen with traditional LNPs. By leveraging machine learning, they’ve built a powerful library of nanocarriers, enabling faster, more efficient therapeutic development. Read more about this collaboration and hear from the co-founder and CEO, Benita Nagel, here ➡️ https://lnkd.in/gMBwYjPJ We're incredibly proud to back companies like Nuntius that are redefining the future of biotech. Get a taste of our bio work by coming to the next #LONDONBIO - tickets will be released next week. #Biotech #mRNATherapeutics #CancerImmunotherapy #GeneticMedicines

Have you developed or seen a Web3 x AI idea you'd love to shout about from the rooftops? 🇸🇬 Share it with us and get involved in the discussion at TOKEN2049 where we are co-hosting the Web3 Meets AI meetup.✌ Henry Ang will be back on home turf and looking forward to reconnecting! So, with 4 weeks to go, it's time to snap up a ticket - apply below.